JM AB (JM.ST) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · Sweden · ISIN SE0000806994
JM AB financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 14.27 bn SEK | 10.69 bn SEK |
| Gross profit | 1.63 bn SEK | 1.26 bn SEK |
| EBIT | 692.00 m SEK | 346.00 m SEK |
| Net income | 353.00 m SEK | 56.00 m SEK |
| Diluted EPS – continuing operations | 5.47 SEK | 0.87 SEK |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About JM AB
JM AB (publ) constructs, develops, and sells housing and residential areas in the Nordic region. The company operates through JM Residential Stockholm, JM Residential Sweden, JM Norway, JM Finland, and JM Property Development segments. It also engages in the acquisition of development properties; planning, pre-construction, production, and sale of residential units; development of rental units, residential care units, and commercial properties; provision of economic and technical management, and housing services to tenant-owners associations; and contract works in the Greater Stockholm area. JM AB (publ) was incorporated in 1945 and is headquartered in Solna, Sweden.
More stocks
- Exmar NV (EXM.BR)
- Suqian Unitech Corp. Ltd. Cl A (603065.SS)
- Borr Drilling Ltd (BORR)
- Oxford Biomedica PLC (OXB.L)
- Suzhou Xianglou New Material Co. Ltd. (301160.SZ)
- Transportation & Logistics Systems, Inc. (TLSS)
- First Watch Restaurant Group, Inc. (FWRG)
- Zhejiang Goldensea Envi Tech C (603311.SS)
- Anhui Landun Photoelectron Co Ltd (300862.SZ)
- Jilin Expressway Co Ltd (601518.SS)
- Cendes Co Ltd Class A (300492.SZ)
- R&G PharmaStudies Co. Ltd. A (301333.SZ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.